UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections

Vaccine, 2012-12, Vol.30 (51), p.7374-7380

2012

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of hemagglutinin targeted influenza virus neutralization

PloS one, 2013-12, Vol.8 (12), p.e80034-e80034

2013

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Cell, 2020-05, Vol.181 (5), p.1016-1035.e19

2020

Link zum Volltext

Verfügbarkeit prüfen

Differentiated human airway organoids to assess infectivity of emerging influenza virus

Proceedings of the National Academy of Sciences - PNAS, 2018-06, Vol.115 (26), p.6822-6827

2018

Link zum Volltext

Verfügbarkeit prüfen

Mutations in the H7 HA and PB1 genes of avian influenza a viruses increase viral pathogenicity and contact transmission in guinea pigs

Emerging microbes & infections, 2019-01, Vol.8 (1), p.1324-1336

2019

Link zum Volltext

Verfügbarkeit prüfen

Aprotinin, a Protease Inhibitor, Suppresses Proteolytic Activation of Pandemic H1N1v Influenza Virus

Antiviral chemistry & chemotherapy, 2011-04, Vol.21 (4), p.169-174

2011

Link zum Volltext

Verfügbarkeit prüfen

Smoking and COVID-19: Adding Fuel to the Flame

International journal of molecular sciences, 2020-09, Vol.21 (18), p.6581

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of inhaled pollutants on response to viral infection in controlled exposures

Journal of allergy and clinical immunology, 2021-12, Vol.148 (6), p.1420-1429

2021

Link zum Volltext

Verfügbarkeit prüfen

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

Pharmacology & therapeutics (Oxford), 2020-09, Vol.213, p.107587-107587, Article 107587

2020

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications

Cellular and molecular life sciences : CMLS, 2022-03, Vol.79 (3), p.142-142, Article 142

2022

Link zum Volltext

Verfügbarkeit prüfen

Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species

PLoS pathogens, 2017-03, Vol.13 (3), p.e1006270-e1006270

2017

Link zum Volltext

Verfügbarkeit prüfen

Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics

Virology journal, 2021-07, Vol.18 (1), p.154-154, Article 154

2021

Link zum Volltext

Verfügbarkeit prüfen

Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy

Pharmacological research, 2022-08, Vol.182, p.106334-106334, Article 106334

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2

International journal of molecular sciences, 2022-07, Vol.23 (13), p.7365

2022

Link zum Volltext

Verfügbarkeit prüfen

Stem cells or their exosomes: which is preferred in COVID-19 treatment?

Biotechnology letters, 2022-02, Vol.44 (2), p.159-177

2022

Link zum Volltext

Verfügbarkeit prüfen

Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS‐CoV‐2 drug targets: in vitro validation of furin inhibition

Phytotherapy research, 2021-02, Vol.35 (2), p.908-919

2021

Link zum Volltext

Verfügbarkeit prüfen

Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design

Vaccines (Basel), 2022-09, Vol.10 (9), p.1520

2022

Link zum Volltext

Verfügbarkeit prüfen

A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2

Pharmacological reports, 2022-04, Vol.74 (2), p.425-430

2022

Link zum Volltext

Verfügbarkeit prüfen

The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2

International journal of molecular sciences, 2022-03, Vol.23 (7), p.3435

2022

Link zum Volltext

Verfügbarkeit prüfen

When stem cells meet COVID-19: recent advances, challenges and future perspectives

Stem cell research & therapy, 2022-01, Vol.13 (1), p.9-16, Article 9

2022

Link zum Volltext

Verfügbarkeit prüfen

A review of potential treatments to date in COVID-19 patients according to the stage of the disease

Current research in translational medicine, 2020-08, Vol.68 (3), p.93-104

2020

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances on Targeting Proteases for Antiviral Development

Viruses, 2024-02, Vol.16 (3), p.366

2024

Link zum Volltext

Verfügbarkeit prüfen

Umbilical cord: an allogenic tissue for potential treatment of COVID-19

Human cell : official journal of Human Cell Research Society, 2021-01, Vol.34 (1), p.1-13

2021

Link zum Volltext

Verfügbarkeit prüfen

Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection

Vaccines (Basel), 2021-07, Vol.9 (7), p.741

2021

Link zum Volltext

Verfügbarkeit prüfen

Avian influenza virus cross‐infections as test case for pandemic preparedness: From epidemiological hazard models to sequence‐based early viral warning systems

Microbial biotechnology, 2024-01, Vol.17 (1), p.e14389-n/a

Brüssow, Harald

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaPandemics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(24)
Humans
(23)
Covid-19
(17)
Influenza
(13)
Sars-Cov-2
(12)
Viruses
(12)
Coronaviruses
(10)
Review
(10)
Severe Acute Respiratory Syndrome Coronavirus 2
(10)
Infections
(9)
Animals
(8)
Hemagglutinins
(6)
Infectious Diseases
(6)
Life Sciences
(6)
Medicine, Research & Experimental
(6)
Research & Experimental Medicine
(6)
Stem Cells
(6)
Ace2
(5)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections

Mechanisms of hemagglutinin targeted influenza virus neutralization

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Differentiated human airway organoids to assess infectivity of emerging influenza virus

Mutations in the H7 HA and PB1 genes of avian influenza a viruses increase viral pathogenicity and contact transmission in guinea pigs

Aprotinin, a Protease Inhibitor, Suppresses Proteolytic Activation of Pandemic H1N1v Influenza Virus

Smoking and COVID-19: Adding Fuel to the Flame

Impact of inhaled pollutants on response to viral infection in controlled exposures

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications

Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species

Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics

Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy

Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2

Stem cells or their exosomes: which is preferred in COVID-19 treatment?

Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS‐CoV‐2 drug targets: in vitro validation of furin inhibition

Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design

A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2

The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2

When stem cells meet COVID-19: recent advances, challenges and future perspectives

A review of potential treatments to date in COVID-19 patients according to the stage of the disease

Recent Advances on Targeting Proteases for Antiviral Development

Umbilical cord: an allogenic tissue for potential treatment of COVID-19

Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection

Avian influenza virus cross‐infections as test case for pandemic preparedness: From epidemiological hazard models to sequence‐based early viral warning systems

Aktive Filter

Suchergebnisse filtern